Dr. Helen Ma, MD

Claim this profile

Tibor Rubin VA Medical Center

Studies Lymphoma
Studies Peripheral T-Cell Lymphoma
4 reported clinical trials
19 drugs studied

Area of expertise

1

Lymphoma

Helen Ma, MD has run 2 trials for Lymphoma. Some of their research focus areas include:

13q positive
13q negative
12 positive
2

Peripheral T-Cell Lymphoma

Helen Ma, MD has run 1 trial for Peripheral T-Cell Lymphoma.

Affiliated Hospitals

Image of trial facility.

Tibor Rubin VA Medical Center

Image of trial facility.

V.A. Long Beach Healthcare System

Clinical Trials Helen Ma, MD is currently running

Image of trial facility.

Azacytidine + Romidepsin

for Peripheral T-Cell Lymphoma

This trial is testing if a combination of two drugs, romidepsin and azacytidine, is safe and effective for patients with aggressive Peripheral T-Cell Lymphoma that hasn't responded to other treatments. The goal is to see if this combination works better than using just one drug alone. Romidepsin is approved for certain types of T-cell lymphoma and has shown positive results in various T-cell cancers.

Recruiting

1 award

Phase 2

11 criteria

Image of trial facility.

Screening Tool

for Myeloid Cancer

This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific laboratory tests to help improve participants' ability to register to clinical trials throughout the course of their myeloid cancer (acute myeloid leukemia or myelodysplastic syndrome) treatment. This study involves testing patients' bone marrow and blood for certain biomarkers. A biomarker (sometimes called a marker) is any molecule in the body that can be measured. Doctors look at markers to learn what is happening in the body. Knowing about certain markers can give doctors more information about what is driving the cancer and how to treat it. Testing patients' bone marrow and blood will show doctors if patients have markers that specific drugs can target. The marker testing in this study will let doctors know if they can match patients with a treatment study (myeloMATCH clinical trial) that tests treatment for the type of cancer they have or continue standard of care treatment with their doctor on the Tier Advancement Pathway (TAP).

Recruiting

0 awards

Phase 2

1 criteria

More about Helen Ma, MD

Clinical Trial Related

4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical Trials

Treatments Helen Ma, MD has experience with

  • Venetoclax
  • Azacytidine
  • Romidepsin
  • Obinutuzumab
  • Cyclophosphamide
  • Oral Azacitidine

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Helen Ma, MD specialize in?

Is Helen Ma, MD currently recruiting for clinical trials?

Are there any treatments that Helen Ma, MD has studied deeply?

What is the best way to schedule an appointment with Helen Ma, MD?

What is the office address of Helen Ma, MD?

Is there any support for travel costs?